The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
even now Neurontin usually ranks a generic neuron and Gabapentin usually ranks between the sixth and 10th most frequently prescribed drug in the United States even now and all that happened in the trial all the fraud and all the um chicanery about designing studies so people had so many side effects they knew they were on neurontin and all that stuff is is public access information
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.